• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Medpace acquires European medical device CRO MediTech Strategic Consultants

Medpace acquires European medical device CRO MediTech Strategic Consultants

November 27, 2012
CenterWatch Staff

Cincinnati-based Medpace, a privately held CRO, has acquired MediTech Strategic Consultants, a European CRO dedicated to medical device clinical trials and services related to development and commercialization of medical devices.

MediTech expands Medpace's European device capabilities both in the development of trial designs and regulatory strategies toward CE Mark, in addition to the conduct of clinical trials and authorized representative and quality system support toward ISO 13485. The acquisition, combined with Medpace's existing medical device division, provides a global solution for medical device development.

MediTech was founded in 2000 by Carla Kikken-Jussen, president and CEO. MediTech has supported clinical trials of medical devices in therapeutic areas including ophthalmology, cardiovascular, gastroenterology, orthopedics and pulmonology. Kikken-Jussen will continue to lead MediTech.

“MediTech's expertise complements and broadens our global medical device service offering,” said Dr. August Troendle, president and CEO of Medpace. “MediTech is well respected in both Europe and the U.S., and this strategic acquisition fully supports Medpace's growth and provides our sponsors a wide range of regulatory and clinical expertise across North America and Europe, along with expanded operational capacity."

Medpace provides phase I-IV core development services for drug, biologic, and device programs. It has more than 1,200 employees and clinical trial experience in over 40 countries. Medpace also provides phase I/IIa clinical services from Medpace Clinical Pharmacology, central laboratory and therapeutically specialized testing from Medpace Reference Laboratories, complete bioanalytical services from Medpace Bioanalytical Laboratories, centralized imaging core laboratory management and reading from Imagepace and medical device development from Medpace Medical Device.

MediTech Strategic Consultants employs more than 40 multinational staff based in the Netherlands, the Czech Republic, Israel and Poland, providing support for trials conducted throughout the European Union and Israel, Norway, Switzerland and Turkey.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing